• Home
  • Study Details
Not currently enrolling

Merck V114 / Prevnar

To Evaluate the Safety, Tolerability, and Immunogenicity of a 4-dose Regimen of V114 (pneumococcal vaccine) in Healthy Infants

Age & Gender

  • 0 years ~ 0 years
  • Male, Female

Contact the Team


Thank you for your interest, but this study is not currently enrolling.

North Carolina (Wake)

Additional Study Information

Principal Investigator

Robert Morgan
UNC Hospitals - UNCPN

Study Topics

Child and Teen Health
Healthy Volunteer or General Population

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.